JAMA
Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery
Chaim M. Bell, MD, PhD; Wendy V. Hatch, OD, MSc; Hadas D. Fischer, MD; Geta Cernat, MD, MSc; J. Michael Paterson, MSc; Andrea Gruneir, PhD; Sudeep S. Gill, MD, MSc; Susan E. Bronskill, PhD; Geoffrey M. Anderson, MD, PhD; Paula A. Rochon, MD, MPH
Context: Both benign prostatic hyperplasia (BPH) and cataract formation are common in older men. The
-adrenergic receptor blocker tamsulosin is frequently prescribed to treat BPH, and research suggests this drug may increase the intraoperative difficulty of cataract surgery. No studies have documented whether use of tamsulosin or other
-blocker drug therapies affect the risk of serious postoperative adverse events.
Objective: To assess the risk of adverse events following cataract surgery in older men prescribed tamsulosin or other
-blocking drugs used to treat BPH.
Design, Setting, and Patients: Nested case-control analysis of . . . [Full Text of this Article]